Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Top Cited Papers
Open Access
Abstract
Lung cancer is the leading cause of cancer mortality worldwide, accounting for ∼1.3 million deaths each year. Overall incidence and epidemiology data are summarised in the ESMO Clinical Practice Guidelines (CPG) on ‘metastatic non-small-cell lung cancer (NSCLC)’ [1].

This publication has 55 references indexed in Scilit: